Israeli Strikes in Gaza Kill at Least 100, Local Health Officials Say

© Saher Alghorra for The New York Times

© Saher Alghorra for The New York Times

© Stella Kalinina for The New York Times

© Matias Delacroix/Associated Press










Storm has left devastation in its path with 120mph winds

© NOAA
Sports giant saw a five per cent dip in North America sales

© Copyright 2022 The Associated Press. All rights reserved.

© Copyright 2025 The Associated Press. All rights reserved.
Over-by-over updates with play from 9.30am GMT
Andy Bull: Ace programme opens doors | Email Tanya
4th over: South Africa 21-0 (Wolvaardt 13, Brits 6) Neat and tidy from Smith. That Bell semi-drop not withstanding, the BBC report that – stats wise - England are the best fielding team in the competition.
3rd over: South Africa 19-0 (Wolvaardt 12, Brits 5) A half-chance not held. Brits flays Bell back back with fire, through the left hand of her follow through and down to the rope.
Continue reading...
© Photograph: Anushree Fadnavis/Reuters

© Photograph: Anushree Fadnavis/Reuters

© Photograph: Anushree Fadnavis/Reuters

© Copyright 2025 The Associated Press. All rights reserved
Most Asian stock markets rally on trade deal optimism, ahead of expected US interest rate cut
As ministers are drawing up proposals to increase the amount the NHS spends on new medicines, potentially by up to 25%, with an announcement expected as soon as the end of this week, GSK boss Emma Walmsley said she was “hopeful and ambitious” that the standoff with the pharma industry can be resolved.
Without pricing reform, the UK will struggle to be a life sciences superpower, she warned. She told reporters:
We are great supporters of the life sciences industrial strategy in the UK. And I’ve been very consistent on our view that it’s key to execute against that in terms of the opportunity for clinical trials and the opportunity for having translational facilities, all of the work that can be done with the data, but it is absolutely key that we have a competitive, commercial environment that recognises the value of innovation.
Obviously we’re engaging, watching, contributing as we can. And, I would say: hopeful and ambitious.
What everyone is putting the energy into, hopefully resolving, is how we make sure this country creates the right commercial environment. And without that, I think it’s going to be very difficult to be able to be a leading life sciences superpower… and without that, we are not going to secure something else we all want, which is patient access to innovation. You have to remember that the cost of drugs as a share of the total cost of health care is less than 10% in this country.
We absolutely agree we should be working towards constructive reform in the US system that we want to have affordable, accessible drugs in a sustainable way.
We remain very cautious about the environment in the US, although we did reassert today, we expect to be at the top end of our current vaccines guidance, and that’s really because we’re seeing great momentum ex US, particularly in Europe this quarter.
Continue reading...
© Photograph: Evelyn Hockstein/Reuters

© Photograph: Evelyn Hockstein/Reuters

© Photograph: Evelyn Hockstein/Reuters

© IHA

© Andrew Cornaga/AP
In a show of military force hours before Trump’s arrival, North Korea launched sea-to-surface cruise missiles into its western waters

© AFP/Getty